.png)
Peptide companies operate in a complex paid-media environment where advertising eligibility can depend on the type of business, product classification, intended use, claims, landing-page content, and target market. A commercial research supplier, wellness company, clinic, and telemedicine provider can face different advertising and certification requirements.
Finding the right peptide marketing agencies therefore requires more than conventional media-buying expertise. Peptide companies may need claim-aware creative, eligible paid-media channels, conversion-focused landing pages, first-party audience development, retention programs, and analytics that connect acquisition with downstream commercial outcomes.
Peptide advertising is not one regulatory or advertising category.
Google's current pharmaceutical advertising policy specifically allows suppliers of antibodies, peptides, and compounds for commercial laboratories to advertise in Canada and the United States, subject to Google's applicable requirements.
That policy should not be interpreted as broad approval for every company selling peptides.
Prescription-drug and telemedicine services can fall under separate healthcare advertising requirements. Businesses involved in remote prescribing, pharmacies, compounded medicines, or other healthcare services may need different certifications and approval pathways.
For businesses navigating these distinctions, a broader regulated marketing framework can help connect channel eligibility, claims, privacy, audience development, and measurement rather than treating paid media as an isolated function.
Regulatory treatment also depends on more than the disclaimer attached to a product.
In 2026, FDA enforcement against peptide sellers reinforced that “research use only” or similar wording does not automatically determine how a product will be treated when other marketing materials indicate intended human use.
In its Gram Peptides warning letter, FDA stated that website evidence showed certain products were intended as drugs for human use despite language describing them as research-only and not intended for human consumption.
Peptide marketers therefore need consistency across:
FTC requirements add another layer. Its health products guidance explains that advertisers are responsible for both express and implied claims and generally need appropriate substantiation for objective health-related representations.
Healthcare certification should also be handled precisely.
LegitScript's healthcare certification covers categories including pharmacies, telemedicine providers, medical spas, digital-health platforms, and pharmaceutical manufacturers. The company also explains that some businesses may not need certification when they do not sell or advertise prescription medications or offer services that trigger platform healthcare requirements.
For peptide companies, this means certification should be evaluated according to the actual business model instead of presented as a universal prerequisite.
A peptide-focused paid-media partner should combine performance marketing with an understanding of platform eligibility and claim-sensitive marketing.
Useful capabilities include:
Agency case studies can provide useful evidence, but company-reported ROAS and revenue figures should be considered within the spend level, campaign period, attribution model, and business type involved.

Herb Agency brings more than 11 years of experience in cannabis and regulated markets. Its relevance to peptide companies comes from applying that broader regulated industry marketing experience to businesses where paid-media eligibility, customer education, claims, and channel diversification require careful coordination.
Herb Agency's marketing services connect paid media with SEO, content, email marketing, first-party audience development, creative, analytics, direct mail, and customer reactivation.
For this category, Herb's paid-media work provides a more relevant proof point than its email-focused case studies.
Herb reports that its Arete Hemp programmatic campaign delivered 617,207 impressions, 2,513 clicks, a 0.41% click-through rate, and $125,558 in influenced revenue.
Herb Agency's strongest public evidence remains cannabis, hemp, CBD, and adjacent regulated categories rather than peptide-specific paid-media case studies. Its fit is therefore strongest for peptide businesses seeking broader regulated-market acquisition and retention infrastructure rather than a peptide-only media buyer.
Peptide Marketing operates exclusively in the peptide and research-chemical category and states that it has worked in the vertical since 2022.
The agency currently reports more than 40 active peptide brands and more than $250 million in managed revenue.
One published engagement describes taking a pre-launch U.S. peptide brand from zero to more than $4 million in monthly revenue over 22 months. The agency reports paid media operating at 3.2x ROAS on more than $1 million in monthly spend, with email contributing 35% of revenue.
These figures are Peptide Marketing-reported case-study outcomes rather than broader industry benchmarks.
.png)
Orange Trail specializes in performance marketing for regulated and high-risk categories including peptides, GLP-1 businesses, CBD, supplements, and nutraceuticals.
Orange Trail currently reports more than $250 million in managed advertising spend and support for more than 500 advertisers.
Its published peptide examples include $405,000 in revenue at a reported 7.41x ROAS and $377,000 in revenue at a reported 7.8x ROAS.
The agency also publishes a longer peptide case study describing a brand that reached more than $150,000 in monthly ad spend with a peak reported ROAS of 8.58x. These are Orange Trail-reported campaign results.
Amino Marketing focuses specifically on growth marketing for research peptide brands, combining acquisition with organic search, email, conversion, and ecommerce infrastructure.
The agency currently reports more than 60 active campaigns across 20 active brands, more than $100 million in total managed revenue, and an average ROAS above 4x.
These are company-reported aggregate figures.
Amino's narrow peptide focus makes it relevant to research-focused brands looking for acquisition and retention support from one provider rather than separating paid media from SEO, email, and web operations.
The AD Leaf provides advertising and marketing services for peptide companies, medical practices, clinics, wellness providers, research businesses, and ecommerce organizations.
The agency's current peptide materials emphasize claim-sensitive campaign planning and consistency between advertising and landing pages.
The AD Leaf also explicitly states that it does not provide legal or medical compliance review. Instead, its marketing workflows are designed to make review by the appropriate business, medical, or legal professionals easier.
That distinction is useful in a category where marketing expertise should not be presented as a substitute for regulatory or legal advice.
Peptide Ads focuses exclusively on research peptide brands and combines paid acquisition with funnels, creative, tracking, lifecycle marketing, and commercial infrastructure.
Its current commercial model combines a monthly retainer with a 7% performance fee on directly attributable revenue, with no long-term contract.
Peptide Ads also works with payment, fulfillment, subscription, and retention infrastructure alongside paid acquisition.
Its published results and performance figures are company-reported and vary by engagement, offer, spend level, and account.
.png)
NexaMed focuses primarily on patient acquisition for peptide clinics and other healthcare businesses rather than research-use-only ecommerce brands.
Its Pure Hydration case study reports 312 consultations booked over 90 days at an $18 cost per consultation.
The same case study reports a 4.2% click-through rate and 6.8x ROAS.
These are NexaMed-reported results from a specific clinic campaign rather than general peptide advertising benchmarks.
Its healthcare orientation makes NexaMed most relevant to provider-led peptide services rather than laboratory-supplier ecommerce.
Oney Studio focuses heavily on Google Ads and performance marketing for peptide and other regulated ecommerce brands.
One published peptide case study describes a brand whose monthly Google Ads conversion value increased from approximately $8,000 to $94,400 within six months after restructuring Search and adding Shopping, Display, and Performance Max.
The same campaign later reached approximately $148,000 in monthly conversion value at a reported 4.6x ROAS.
Oney also publishes additional peptide case studies covering cold-start campaigns and higher-volume ecommerce accounts. These are Oney-reported client results.
247 Digital Marketing provides full-service marketing for peptide companies across paid acquisition, SEO, ecommerce, content, web development, and conversion optimization.
The agency currently reports an average 200% lift in qualified peptide sales from its campaigns, up to a 72% increase in email engagement, and up to 310% organic-traffic growth.
These are company-reported aggregate results.
Its Peptide Hubs portfolio also reports a 47% reduction in cost per acquisition alongside increased organic traffic, conversions, and social engagement during a multi-channel engagement.
Pro Marketer maintains a dedicated peptide marketing offering for research peptide businesses, wellness brands, clinics, and DTC companies.
Its approach distinguishes between research-focused companies, wellness businesses, and provider-led models rather than applying one campaign structure to every peptide advertiser.
The agency also combines acquisition with retention and ecommerce optimization, making it relevant to companies looking for paid-media support within a broader digital marketing program.
.png)
The starting point for peptide paid media should be determining the company's peptide business model, what it sells, who the intended customer is, and how the product or service is positioned.
A pre-launch review can include:
For research-focused businesses, research-use-only positioning should remain consistent throughout the marketing experience.
A disclaimer cannot reliably resolve conflicts created by human-use claims elsewhere on a website.
Depending on the company and product, paid acquisition can involve combinations of:
A commercial laboratory supplier may have advertising options that differ substantially from a peptide clinic or telemedicine provider.
The media plan should therefore follow confirmed eligibility rather than trying to force the same channels onto every business.
Paid acquisition becomes more resilient when a business can continue customer relationships beyond an individual advertising platform.
A first-party audience strategy can connect eligible customer engagement with permission-based email, CRM activity, customer accounts, and retention programs.
Peptide companies should still consider the sensitivity of information being collected and the privacy obligations associated with their specific business model.
Relevant retention measures can include:
Connecting acquisition with customer retention can provide a clearer view of whether paid media is attracting customers who continue generating value.
ROAS remains useful, but it should be interpreted alongside the agency's attribution model.
Other useful measures include:
An analytics measurement framework can connect acquisition with subsequent customer activity rather than treating the initial click as the entire journey.
Direct, assisted, and influenced outcomes should remain clearly differentiated.
Some advertising providers use cloaking or similar techniques that present one version of a destination to advertising-platform reviewers and another to users.
Google's circumventing systems policy prohibits cloaking designed to hide noncompliant content or otherwise bypass enforcement.
For peptide companies, a more sustainable approach is to establish genuine platform eligibility, maintain accurate business information, use appropriate certifications where required, and keep advertising consistent with the destination users actually see.
.png)
Herb Agency's role in this category is different from peptide-only agencies that concentrate primarily on managing ad accounts.
Its regulated-market model is relevant when a business wants paid acquisition connected with additional channels that can continue generating value even when individual advertising platforms become constrained.
That can include:
The Arete Hemp campaign provides a relevant example of this paid-media model. Herb reports 617,207 programmatic impressions, 2,513 clicks, a 0.41% click-through rate, and $125,558 in influenced revenue.
The relevance to peptide companies is the connected operating model rather than the individual campaign result. Paid acquisition can bring new audiences into the business while owned channels, organic discovery, retention, and measurement provide additional ways to maintain those customer relationships.
For peptide businesses, the appropriate setup will still depend on whether the organization is a research supplier, ecommerce company, clinic, telemedicine provider, or another type of healthcare or wellness business.
Teams can talk with Herb about their business model, available paid-media channels, audience strategy, and measurement priorities.